References
- Lung.org. [homepage on the Internet]American lung association. COPD fact sheet [updated 2011] Available from: http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.htmlAccessed July 20, 2017
- LandisSHMuellerovaHManninoDMContinuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013Int J Chron Obstruct Pulmon Dis2014959761124944511
- ChenWThomasJSadatsafaviMFitzgeraldJMRisk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysisLancet Respir Med20153863163926208998
- Global initiative for chronic obstructive lung disease (GOLD) [homepage on the Internet]2016 Available from: http://goo.gl/ItQL3aAccessed May 4, 2016
- BarjaktarevicIZArredondoAFCooperCBPositioning new phar-macotherapies for COPDInt J Chron Obstruct Pulmon Dis2015101427144226244017
- SinDDManSFChronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalityProc Am Thorac Soc20052181116113462
- van den BergMEStrickerBHBrusselleGGLahousseLChronic obstructive pulmonary disease and sudden cardiac death: A systematic reviewTrends Cardiovasc Med201626760661327234353
- DecramerMLHananiaNALötvallJOYawnBPThe safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20138536423378756
- ChowdhuryBAdal PanGThe FDA and safe use of long-acting beta-agonists in the treatment of asthmaN Engl J Med2010362131169117120181964
- ChowdhuryBASeymourSMLevensonMSAssessing the safety of adding LABAs to inhaled corticosteroids for treating asthmaN Engl J Med2011364262473247521714647
- WilcheskyMErnstPBrophyJMPlattRWSuissaSBronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohortChest2012142230531122871756
- FDA.gov. [homepage on the Internet]FDA drug safety communication: New safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs)2010 Available from: http://bit.ly/2ryDZitAccessed June 16, 2017
- GrossNJDonohueJFNebulized formoterol: a review of clinical efficacy and safety in COPDInt J Chron Obstruct Pulmon Dis2010522323220714376
- GrossNJNelsonHSLapidusRJEfficacy and safety of formot-erol fumarate delivered by nebulization to COPD patientsRespir Med2008102218919718363201
- TashkinDPA review of nebulized drug delivery in COPDInt J Chron Obstruct Pulmon Dis2016112585259627799757
- ICHIntegrated addendum to ICH harmonised guideline: Guideline for good clinical practice E6 (R2)2015 Available from: https://goo.gl/CFOmR3Accessed July 20, 2017
- VogelmeierCFCrinerGJMartinezFJGlobal strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summaryAm J Respir Crit Care Med2017195555758228128970
- MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
- JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
- MahlerDAWeinbergDHWellsCKFeinsteinARThe measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexesChest19848567517586723384
- BaumgartnerRAHananiaNACalhounWJSahnSASciarappaKHanrahanJPNebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trialClin Ther200729226127817472819
- CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
- BrookRDAndersonJACalverleyPMCardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular riskHeart2017103191536154228416587
- DonohueJFHananiaNAMakeBOne-year safety and efficacy study of arformoterol tartrate in patients with moderate to severe COPDChest201414661531154225451347
- DonohueJFHananiaNASciarappaKAArformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and toleranceTher Adv Respir Dis200822374819124357
- TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213